Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 01, 2015 5:29 AM ET

Pharmaceuticals

Company Overview of Heptares Therapeutics Ltd.

Key Executives for Heptares Therapeutics Ltd.

NameBoard RelationshipsTitleAge
Malcolm Weir Ph.D.6 RelationshipsFounder, Chief Executive Officer and Director--
Daniel Grau M.Phil.23 RelationshipsPresident of USA Operations47
Miles Congreve No RelationshipsHead of Chemistry--
Tim Tasker No RelationshipsChief Medical Officer and Vice President of Development61

Heptares Therapeutics Ltd. Board Members*

NameBoard RelationshipsPrimary CompanyAge
John Edward Berriman BA, BSc MSc, MBA 56 RelationshipsLonza Biologics PLC66
Malcolm Weir Ph.D. 6 RelationshipsHeptares Therapeutics Ltd.--
Michael Steinmetz Ph.D. 125 RelationshipsClarus Ventures, LLC67
Anja König Ph.D. 35 RelationshipsNovartis Venture Funds--
David Brown Ph.D., FRSC 43 RelationshipsAmura Holdings Limited--
View All Board Members

Heptares Therapeutics Ltd. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
424.2K
Bonus
563.7K
Total Short Term Compensation
609.9K
Total Value of Options
22.7M
Compensation as of Fiscal Year
Heptares Therapeutics Ltd. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

EMS Find, Inc. Announces Board Changes
March 26, 2015 9:25 PM ET
WD-40 Company Appoints Melissa Claassen to Board of Directors; Declares Regular Quarterly Dividend, Payable on April 30, 2015
March 24, 2015 3:47 PM ET
ZIL Limited Announces Board Changes
March 17, 2015 10:42 AM ET
Colgate-Palmolive Announces Board Changes
March 13, 2015 1:00 PM ET
Eveready Industries India Limited Announces the Demise of Deepak Khaitan, Vice-Chairman and Non- Executive Director
March 09, 2015 12:00 AM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Heptares Therapeutics Ltd., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.